Natural Alternatives International, Inc. balance sheet NAII

Annual Quarterly

As of Jun 30, 2026, Natural Alternatives International, Inc. had total assets of $126.4 million and total liabilities of $76.5 million. Total assets were down 16.8% from a year earlier. Stockholders' equity was $50.0 million. It held $7.4 million in cash and investments against $40.1 million of total debt, net debt of $32.8 million. The current ratio, current assets divided by current liabilities, was 1.73.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q4 FY2026
Jun 30, 2026
Q3 FY2026
Mar 31, 2026
Q2 FY2026
Dec 31, 2025
Q1 FY2026
Sep 30, 2025
Q4 FY2025
Jun 30, 2025
Q3 FY2025
Mar 31, 2025
Q2 FY2025
Dec 31, 2024
Q1 FY2025
Sep 30, 2024
Assets
Cash
7
-40.1%
9
-13.3%
4
-56.7%
8
-23.7%
12
+2.9%
11
-14.5%
9
-47.8%
10
-39.4%
Cash and investments
7
-40.1%
9
-13.3%
4
-56.7%
8
-23.7%
12
+2.9%
11
-14.5%
9
-47.8%
10
-39.4%
Receivables
21
+41.0%
21
+76.7%
18
+5.1%
19
+7.3%
15
-13.3%
12
+3.8%
17
+61.6%
18
+80.7%
Inventory
31
+23.7%
30
+10.9%
33
+45.1%
31
+18.2%
25
+2.6%
27
+28.1%
23
+17.6%
26
+11.3%
Total current assets
65
+10.4%
64
+9.4%
62
+5.1%
65
+4.1%
59
-3.8%
59
+7.6%
59
+7.6%
62
+8.2%
Property and equipment, net
36
-30.0%
51
+0.5%
51
+0.6%
51
-0.5%
51
-2.5%
51
-3.5%
51
-4.3%
51
-5.4%
Total assets
126
-16.8%
155
-0.0%
153
-1.8%
157
-2.7%
152
-6.4%
155
+1.1%
156
+0.3%
161
+0.6%
Liabilities and equity
Accounts payable
18
+18.2%
18
+41.6%
17
+92.5%
20
+102.1%
15
+20.5%
13
+83.9%
9
+14.7%
10
+30.6%
Total current liabilities
38
+30.9%
39
+67.8%
33
+51.7%
34
+38.7%
29
+22.8%
23
+70.8%
22
+61.4%
24
+58.3%
Total liabilities
76
-8.4%
92
+17.2%
86
+12.0%
88
+8.4%
84
+4.7%
78
+13.3%
77
+9.5%
81
+13.5%
Stockholders' equity
50
-27.0%
63
-17.6%
67
-15.3%
69
-13.9%
68
-17.2%
77
-8.9%
79
-7.4%
80
-9.7%
Debt
Lease liabilities
40
-18.4%
46
-2.0%
47
-1.0%
48
-2.6%
49
+3.0%
47
+1.9%
48
-0.7%
49
+4.2%
Total debt
40
-18.4%
46
-2.0%
47
-1.0%
48
-2.6%
49
+3.0%
47
+1.9%
48
-0.7%
49
+4.2%
Net cash
-33
+11.1%
-37
-1.2%
-43
-11.4%
-40
-3.0%
-37
-3.0%
-37
-7.8%
-39
-24.2%
-39
-28.4%
Ratios
Current ratio
1.73x
1.64x
1.87x
1.92x
2.06x
2.51x
2.70x
2.56x
Debt to equity
0.80x
0.74x
0.70x
0.69x
0.72x
0.62x
0.60x
0.61x
Return on equity
-41.42%
-22.77%
-18.27%
-17.22%
-19.84%
-10.75%
-9.63%
-10.61%
Return on assets
-16.37%
-9.28%
-7.99%
-7.57%
-8.93%
-5.31%
-4.88%
-5.27%
Book value per share
7.97
10.06
10.85
11.17
11.08
12.40
12.77
12.94
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
NAII (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
787253

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.